Journal of Viral Hepatitis

Cover image for Vol. 11 Issue 5

September 2004

Volume 11, Issue 5

Pages 383–478

  1. Review Article

    1. Top of page
    2. Review Article
    3. Original Articles
  2. Original Articles

    1. Top of page
    2. Review Article
    3. Original Articles
    1. Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells (pages 394–403)

      S. Maekawa, N. Enomoto, N. Sakamoto, M. Kurosaki, E. Ueda, T. Kohashi, H. Watanabe, C.-H. Chen, T. Yamashiro, Y. Tanabe, N. Kanazawa, M. Nakagawa, C. Sato and M. Watanabe

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00525.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
    2. Interferon-γ-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes (pages 404–417)

      Y. Wang, J. R. Jacob, S. Menne, C. A. Bellezza, B. C. Tennant, J. L. Gerin and P. J. Cote

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00529.x

      • image
      • image
      • image
      • image
      • image
      • image
    3. Racial differences in responses to interferon-β-1a in chronic hepatitis C unresponsive to interferon-α: a better response in Chinese patients (pages 418–426)

      P.-N. Cheng, P. Marcellin, B. Bacon, G. Farrell, I. Parsons, T. Wee and T.-T. Chang

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00514.x

    4. The use of lamivudine for patients with acute hepatitis B (a series of cases) (pages 427–431)

      L. A. Kondili, H. Osman and D. Mutimer

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00504.x

    5. High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance (pages 439–442)

      P. Andreone, A. Gramenzi, C. Cursaro, M. Biselli, C. Cammà, F. Trevisani and M. Bernardi

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00564.x

      • image
    6. Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine daily (pages 443–447)

      C. C. Wang, S. Holte, M.-L. Huang, S. L. Sacks, R. Engelberg, J. Ferrenberg, M. Shuhart and L. Corey

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00523.x

      • image
      • image
    7. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections (pages 455–458)

      C. Hézode, F. Roudot-Thoraval, E.-S. Zafrani, D. Dhumeaux and J.-M. Pawlotsky

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00528.x

    8. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance (pages 459–464)

      L. J. Yee, P. Kelleher, R. D. Goldin, S. Marshall, H. C. Thomas, A. Alberti, M. Chiaramonte, J.-H. Braconier, A. J. Hall and M. R. Thursz

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00530.x

      • image
      • image
    9. HCV infection and oral lichen planus: a weak association when HCV is endemic (pages 465–470)

      G. Campisi, S. Fedele, L. Lo Russo, O. Di Fede, P. Aricò, A. Craxì and M. D. Mignogna

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00532.x

    10. Hepatitis C virus infection in Egyptian children: single centre experience (pages 471–476)

      M. S. El-Raziky, M. El-Hawary, N. El-Koofy, S. Okasha, M. Kotb, K. Salama, G. Esmat, M. El-Raziky, A. M. Abouzied and H. El-Karaksy

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00535.x

    11. Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1 (pages 477–478)

      D. Dimitroulopoulos, S. P. Dourakis, D. Xinopoulos, K. Tsamakidis and E. Paraskevas

      Version of Record online: 9 SEP 2004 | DOI: 10.1111/j.1365-2893.2004.00536.x

SEARCH

SEARCH BY CITATION